华纳药厂(688799.SH)：获得药品注册证书

Core Viewpoint - Warner Pharmaceuticals (688799.SH) has received approval from the National Medical Products Administration for the registration of Isoproterenol Hydrochloride Injection, which is intended for treating cardiogenic or infectious shock and complete atrioventricular block, as well as cardiac arrest [1] Group 1 - The drug is classified as a Class 3 chemical drug under the new registration category and is considered to have passed the consistency evaluation [1] - The approval of Isoproterenol Hydrochloride Injection enriches the company's formulation product variety and positively impacts the optimization of the company's product structure [1] - The acquisition of the drug registration certificate is not expected to have a significant impact on the company's recent performance [1]